Patients were considered eligible for inclusion if they were greater than 1 year of age and had a confirmed diagnosis of HAE based on a clinical history of angioedema and prior abnormally low C1-INH functional testing (based on Siemens chromogenic assay) on at least two separate occasions. The gene discussed is SERPING1; the disease is hereditary angioedema.